What is Sales and Marketing Strategy of GoodRx Company?

SEO for drug names, conditions, and pharmacy comparisons remains foundational, complemented by SEM, ASO, and high-intent landing pages with localized pricing to drive conversion.

Paid search and social expand reach; retargeting and lookalike audiences reduce CAC while programmatic buys pursue efficiency.

National TV, CTV, YouTube, and radio reinforce the savings message; 2023–2024 spend shifted toward accountable CTV and programmatic video informed by MMM and MTA.

Email, SMS, and in-app messaging deliver refill reminders, price-drop alerts, and dynamic offers; experimentation (A/B, multi-armed bandit) optimizes redemption and LTV.

Patient-facing drug guides and affordability articles rank for long-tail queries while provider-facing content, webinars, and CME-style briefings support EHR engagement and prescriber trust.

First-party intent signals and predictive models tailor coupons and Gold upsell prompts; geo-lift and incrementality testing validate channel impact and inform spend.

Free coupons, subscription membership, provider-embedded price checks, and manufacturer co-pay connections create multiple monetization paths.

Quick workflow: find price, show code, save up to 80% off retail cash price on select drugs—message tailored for inflation-era affordability.

Millions of app downloads and top rankings in medical app stores support credibility; consumer awards for money-saving apps reinforce trust.

Uniform messaging across web, app, TV, in-pharmacy, and provider touchpoints ensures a coherent brand experience and supports GoodRx sales strategy and GoodRx marketing strategy.

Against retail and PBM threats, emphasizes acceptance, convenience, and total savings delivered to defend market share and partner channels.

Organic search, paid acquisition, TV, and provider integrations drive GoodRx customer acquisition and support GoodRx digital marketing and CRM retention strategies.

Launched monetization of intent data and pharma programs with co‑branded patient support and on‑platform media. Channels: GoodRx media placements, email, search, social; result: double‑digit manufacturer revenue growth and higher‑margin mix.

Consistent theme: clear financial proof points and ubiquitous pharmacy context. Success drivers included strong MMM‑verified incrementality and refill‑cadence targeting for subscriptions.

Blend of national broadcast/CTV for brand plus paid search, SEO, CRM, and in‑app conversion tactics for acquisition and retention drove sustained MAU and revenue; GoodRx reported record MAUs and revenue growth post‑IPO and continued subscription ARPU gains through 2024.

Lessons from a large grocer disruption led to diversifying PBM and retail partners to reduce single‑partner exposure and maintain redemption conversion stability.

Emphasis on closed‑loop attribution for manufacturer solutions and MMM for national campaigns improved ROI visibility and compliant audience targeting for pharma programs.

Campaigns materially increased app installs, stabilized organic and paid traffic during inflationary pressure, and lifted coupon redemptions; subscriptions contributed to a meaningful mid‑teens revenue share by 2024.